The Front-End Shift: Prioritizing Dedicated Patient Engagement Beyond Hub and Specialty Pharmacy

Much of today’s patient support is structured around the prescription — access, fulfillment, logistics. But some of the moments that most influence whether a patient initiates, adheres, and persists tend to happen somewhere else entirely: in the space between the prescription and the patient.

Recent industry data indicates that more than 80% of outsourced patient and HCP engagement is delivered by HUBs and specialty pharmacies. While these partners are essential to the ecosystem, their focus and strengths tend to lie in back-end prescription processing, which can leave less room for the high-touch, human engagement that often supports adherence and persistence.

What often receives less attention is the patient’s experience of starting therapy — the emotional, behavioral, and clinical questions that drive whether someone initiates, stays adherent, and persists over time.

Patients are falling off before they ever really start

The numbers suggest where the gaps may be.

An estimated 20-30% of patients never initiate their first prescription. Of those who do, more than half discontinue within 12 months. Treatment initiation alone commonly exceeds 30 days for many therapies.

These are not just operational metrics. They can represent real moments where patients are left without a clear point of contact, without answers to the questions that come up between appointments, and without the confidence they need to begin and stay on therapy.

When engagement is layered onto prescription processing rather than built around the patient, the gaps can become harder to see from the inside and harder to navigate from the patient’s perspective.

The industry is rethinking how patient support is structured

Manufacturers are beginning to look more closely at how their patient support programs are designed and whether the structure matches where patients need the most help. The movement appears to be toward purpose-built, front-end engagement models that address the human and behavioral drivers of therapy initiation and persistence — not as a replacement for HUB and specialty pharmacy partners, but as a critical complement within an overall support model that includes the requisite HUB/SP elements.

In fact, experts expect patient and HCP engagement to grow to 50–60% of total support services spend by 2029, up 5–10% from today.

That shift suggests recognition that the front end of the patient experience deserves its own infrastructure. Not a feature within an existing model, but a distinct capability designed around the moments that shape whether a patient starts therapy and stays on it.

What it looks like when engagement is built around the patient

Front-end engagement is not about replacing what is already in place. Back-end-focused models were designed to solve for access, fulfillment, and logistics — and they do that well. But they were not built to address the human side of therapy: the unanswered questions, the emotional weight of a new diagnosis, the hesitation before a first fill, or the everyday barriers that cause patients to drop off. Front-end engagement is about filling those gaps.

In practice, that can mean:

• A consistent, empathetic point of contact who guides a patient across access, affordability, and adherence from the start
• High-touch support within hours of prescription, not days or weeks later
• Purpose-built solutions that address clinical and emotional barriers to initiation, not just administrative ones
• Seamless integration with existing HUBs, specialty pharmacies, and access vendors, so the patient experiences one coordinated journey rather than multiple disconnected ones

Prioritizing patient engagement for pivotal moments

The patient experience doesn’t begin when the medication ships — and for many patients, it may begin well before the prescription is even written. In fact, the window between prescription and first fill often emerges as one of the most pivotal chapters in the journey. It’s where motivation can erode, questions may go unanswered, and the decision to begin therapy can quietly shift.

Organizations prioritizing front-end engagement appear to be seeing a difference in the outcomes that matter most to patients: persistence, confidence, and a more supported start to therapy. Those that aren’t may find it increasingly difficult to close the gaps patients are experiencing today.

The front-end shift isn’t a future conversation — it’s a current one. The question worth asking is whether today’s support programs are structured to meet it.